ArticleJournal of anesthesia2026
Analysis of perioperative antibiotic usage in the operating room during the 2019 cefazolin shortage in Japan: a multicenter observational study.
Article in Journal of anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeA stable supply of pharmaceuticals is essential for safe perioperative management. In 2019, Japan experienced a nationwide shortage of cefazolin (CEZ), a first-line prophylactic antibiotic, following the suspension of shipments by a major manufacturer (Company A). This study aimed to examine how this shortage influenced perioperative antibiotic selection in operating rooms across Japan.
methodsWe analyzed antibiotic usage data at 37 of 42 facilities that participated in the Japanese Epidemiologic Study for Perioperative Anaphylaxis (JESPA, UMIN000035350) from July 2019 to July 2020. The usage frequency of each antibiotic administered under general anesthesia was evaluated. Statistical analyses included the Mann-Whitney U test and multivariable linear regression, with CEZ usage proportion as the dependent variable.
resultsDuring the CEZ shortage period (July to December 2019), CEZ usage decreased, whereas the use of alternatives such as cefmetazole, flomoxef, sulbactam/ampicillin, and clindamycin increased. Facilities supplied exclusively by Company A (Group A) showed a significantly greater decline in CEZ usage than those with other/multiple suppliers (Group B) (p < 0.001). Multivariable analysis identified manufacturer group as the only significant factor associated with CEZ usage (Group B vs. Group A: β = 2.11, 95% CI 1.52 to 2.71, p < 0.001; adjusted R
conclusionThe drop in CEZ supply reduced its perioperative use and increased reliance on alternative antimicrobials. The impact was less severe at facilities with multiple suppliers, suggesting supplier diversification may help mitigate future shortages. These findings, based on actual administration data from operating rooms across Japan, provide insights for ensuring a stable antibiotic supply.
Indexed as
Identifiers
41844876What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.